Dexamethasone, a synthetic glucocorticoid (GC), is clinically administered to woman at risk for premature labor to induce fetal lung maturation. However, exposure to repeated or excess GCs leads to intrauterine growth restriction (IUGR) and subsequently increases risk of psychiatric and cardio-metabolic diseases in later life through fetal programming mechanisms. GCs are key mediators of stress responses, therefore, maternal nutrient restriction or psychological stress during pregnancy also causes negative impacts on birth and neurodevelopment outcome of fetuses, and other congenital defects, such as craniofacial and skeletal abnormalities. In this study, to examine the effect of prenatal stress on fetal skeletal development, dexamethasone (1 mg/kg [DEX1] or 10 mg/kg [DEX10] maternal body weight per day) was administered intraperitoneally at gestational day 7.5~9.5 and the skeletons were prepared from embryos at day 18.5. Seven out of eighteen (39%) embryos treated with DEX10 showed axial skeletal abnormalities in either the T13 or L1 vertebrae. In addition, examination of the sternum revealed that xiphoid process, the protrusive triangular part of the lower end of the sternum, was bent more outward or inward in DEX group embryos. In conclusion, our findings suggest a possible link to the understanding of the effect of uterine environment to the fetal skeletal features.
INTRODUCTION
Glucocorticoids (GCs) are involved in normal developmental processes of diverse organs such as kidneys, lung, heart, pancreas, and gut. As GC has multiple metabolic and immunological effects, it is usually applied to treat patients with inflammatory, allergic, and immune disorders in children and adults. Although it has many positive effects with drug use, patients taking chronic GC therapy often suffer from potential side effects, in particular on the skeleton, including growth retardation during childhood and decreased bone quality in adults (Canalis 2005; Henneicke et al., 2014) . During pregnancy, GC is clinically administered to pregnant woman at risk for premature labor to induce fetal lung maturation (Ward 1994; Sloboda et al., 2005) . Despite the clear benefits of antenatal GC therapy, exposure to repeated or excess GCs have been known to cause a intrauterine growth restriction and subsequently increased risk of psychiatric and cardio-metabolic diseases in later life (Newnham and Moss 2001) . Besides, different types of prenatal stress during pregnancy have been also revealed to cause other congenital defects, such as craniofacial and skeletal anomalies as well as a reduction of birth weight, in a variety of animal models (Śliwa et al., 2006; Lee et al., 2008; Choe et al., 2011) .
A few studies have demonstrated the effect of prenatal
Original Article stress and excess glucocorticoid on fetal skeletal development, and on skeletal growth and bone mineralization after birth as a long-term effect (Swolin-Eide et al., 2002; Śliwa et al., 2006; Lee et al., 2008; Choe et al., 2011) . However, there is still no coherent connection between a specific type of stressor and the concomitant skeletal changes. Since the prenatal stress affects on different tissues in a variety of different ways, particularly during vulnerable periods of developmental processes, more evidence is needed to determine the relationship between prenatal experiences and the skeletal growth and the bone health in later life.
We have recently demonstrated that administration of dexamethasone (DEX), a synthetic GC, during the gestational day 7.5~9.5 of pregnant mice causes placental defect and embryonic growth restriction in a sex-dependent manner (Lee et al., 2012; Yun et al., 2014) . Here, we examined the effect of prenatal DEX treatment on fetal skeletal development on day 18.5. Developmental defects of the axial skeleton found in this model will provide an insight into the long-lasting effect of prenatal GC on the growth and the maturity of the skeleton.
MATERIALS AND METHODS

Experimental animals and injection of DEX
All animals were handled according to the guideline for the Care and Use of Laboratory Animals of Yonsei University College of Medicine. The protocol for obtaining embryos was approved by the Committee on Animal
Research at Yonsei University College of Medicine. Pregnant ICR mice were ordered from Orient Biology (Sungnam, Korea). DEX administration was performed as previously described (Lee et al., 2012) . Briefly, either saline (control group) or dexamethasone 21-phosphate disodium salt (1 mg/ kg or 10 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) was injected on days 7.5, 8.5 and 9.5 of gestation intraperitoneally.
Embryo extraction and skeleton preparation
The mice were sacrificed at 10 a.m. on gestational day 18.5 using a carbon dioxide chamber. Embryos were extracted from the womb and the body weight and CRL (Crown-rump length) measured. Each sample's skin and internal organs in the chest cavity and lower trunk were removed after being incubated at 70℃ for 1 hour. They were fixed in 95% ethanol for 2~4 days and transferred to glass bottles containing acetone and kept overnight. Each sample was washed and stained with 0.03% Alcian Blue solution (Sigma) overnight. After being put in 95% ethanol for 3 hours, the embryos were stored in 2% potassium hydroxide in distilled water (DW) for 24 hours and stained with 0.005% Alizarin Red solution (Sigma) for 16 hours.
The samples were then cleared in 1% potassium hydroxide in 20% glycerol for 2 days and transferred to increasingly concentrated glycerol solutions (50% to 80% glycerol in 95% ethanol solution for 1 day each).
Microscope observation and identification
The samples were observed using a light microscope (Olympus SZX10) under varying degrees of brightness and hue. Each spinal column was identified using dorsal and ventral views of the trunk and several anatomical landmarks (T6 and T7 ribs conjoin near the end of the sternum, vertebral columns after caudal 4 lack dorsal processes, etc.).
Embryos exposed to DEX were compared to specimens of the control group for abnormalities in the skeletal structure.
RESULTS
Effect of prenatal DEX treatment on fetal vertebral column
A total of 36 embryos (18 embryos from 3 mothers with saline, and the same number with 1 mg/kg of DEX (DEX1) and 10 mg/kg of DEX (DEX10), respectively) were processed for skeletal preparation at gestational day 18.5. As far as the skeletal system is concerned, all the structures in the vertebral column including cervical, thoracic, lumbar, sacral and caudal were examined and overall no significant difference was observed except on the region between the last thoracic (T13) and the first lumbar (L1) vertebrae ( Fig.   1A and B). Table 1 summarized the axial skeletal alterations observed in control and DEX group. In our experimental groups, low dose of DEX treatment (DEX1) did not cause any changes in skeletal formation. Contrarily, out of 18 embryos in the DEX10 group, 6 embryos (33%) showed a pair of ectopic ribs on one or both side of L1 spinal column indicating an L1 to T13 transformation. In addition, 1 embryo (6%) showed less developed T13 ribs. The ectopic L1 ribs were shorter than T13 ribs and varied from a stumplike growth to a pair of bony appendages with cartilaginous ends ( Fig. 1C and D) . The upper thoracic ribs of these samples were similar to that of control group embryos.
Deformed T13 ribs were shorter in length compared to those of control group embryos (Fig. 1E) . In this embryo, upper ribs such as T10, 11 and 12 also seemed to be less developed, as their costal cartilages were shorter and less curved around the chest cavity than those of control group embryos. There was no sex preference on these phenotypes.
Effect of prenatal DEX treatment on the protrusion of xiphoid process
The xiphoid process, indicated in Fig. 2A , is a small cartilaginous process (extension) of the lower part of the sternum. Examination of the sternum have revealed that the xiphoid process in embryos from experimental groups was bent more outward or inward compared to those of control group (Fig. 2B-D and Fig. 3 ). The y-axis presented in Fig. 3 was an angle between the sternum and the protruding end of the xiphoid process in each embryo. The individuals belonging to the upper outside from the strong dotted line (Mean + SD) in the graph were the embryos possessing xiphoid process that points outward from of the rib cage which bent the sternum into a convex shape (Fig.   2C ). In contrast, the ones belonging to the lower outside from the weak dotted line (Mean -SD) showed inward pointing xiphoid process that bent the sternum into a concave shape (Fig. 2D) . Female embryos in control saline group were distributed almost equally on the outside or within the criteria 'Mean ± SD'. Whereas, large proportion of female embryos in DEX1 group (8 out of 9 females) role of GC in regulating bone formation, GCs have been implicated in the induction of osteoblast differentiation and maintenance of bone homeostasis on a physiological level (Eijken et al., 2006; Henneicke et al., 2014) . However, depending on GC dose and duration of experimental condition, as well as in the clinical use of GC for therapy, excess GC has been frequently caused negative effects, such as bone loss or osteoporosis (Weinstein 2011; Henneicke et al., 2014) . Similar to the undesirable results of excess GC on bones during the postnatal and adult stages, prenatal GC may also affect skeletal formation during fetal stages and can be programmed.
Maternal restraint stress or DEX exposure in animal models resulted in vertebral and sternal abnormalities, and the retardation of somite and limb formation (Śliwa et al., 2006; Lee et al., 2008; Choe et al., 2011) . Several human studies have demonstrated that prenatal GC treatment led to a transient suppression of the levels of carboxy-terminal propeptide of type I collage (PICP) and carboxy-teminal telopeptide of type I collagen (ICTP), a measure to assess the rate of bone formation and resorptive, respectively, but with no long-term impact (Korakaki et al., 2007; Korakaki et al., 2011) . However, interestingly enough, Gale et al. have shown that genetic and/or intrauterine environmental factors influenced the fetal growth trajectory and suggested an evidence that low birth weight was associated with lower adult bone and muscle mass, and the risk of osteoporosis in later life (Gale et al., 2001) . Therefore, the effects of prenatal GC or other type of stress on bone formation during fetal development and potential impacts over the whole life need to be investigated by specific details.
The vertebrate axial skeleton is composed of cervical, and c10, has been proposed as GC-regulated genes, in mouse skin (Donet et al., 2008) . We have been previously demonstrated that prenatal DEX exposure induces dysregulation of Hox gene expression in mouse embryos . The similarities of the prenatal DEX-induced phenotypes on skeleton observed in this study, e.g. an ectopic ribs on the L1 vertebrae, with those found in mutants for the Hox paralogous groups 8-10 (Favier and Dolle 1997; van Den Akker et al., 2001; Wellik and Capecchi 2003) suggest possible molecular mechanisms that underlie the detrimental effects of prenatal DEX on skeletal development.
Although there were 2 embryos showing supernumerary ribs on the L1 in control group, natural occurrence of the homeotic transformation have been also found at low frequencies within a wild-type population in other studies (del Mar Lorente et al., 2000; van Den Akker et al., 2001; Lorente et al., 2006) . Therefore, we do not think that saline injection only caused significant changes in axial skeleton. Within Mean ± SD of saline group 5 (56) 1 (11) 6 (50) 8 (89) 5 (56) 8 (67) Outside of Mean ± SD of saline group 4 (44) 8 (89) 6 (50) 1 (11) 4 (44) 3 (33) The number in parentheses represents a percentage of embryo of a given population.
Xiphoid process is a small cartilaginous extension of the lower part of the sternum which is usually ossified in the adult human. The abnormal forward or inward curvature of xiphoid process are not detrimental to the overall health status, but may contribute to the anatomically significant chest deformities, such as pectus excavatum (PE) and pectus carinatum (PC). Patients with PE and PC deformities may feel uncomfortable strains and are unsatisfied with a cosmetic deformity; however, depending on severity, those can impair cardiac and pulmonary function that will be considered for surgical correction Robicsek et al., 2009) . Although these type of abnormalities are congenital, neither the systematic analysis of the genetic and molecular mechanisms nor the effects of the early uterine environment have been identified. Based on our observation, the angle divergence between the sternum and the protruding end of the xiphoid process was bigger in female embryos than in male embryos. Sex differences in the effect of prenatal glucocorticoid exposure or stress have now been issued in this field (Bale 2011; Glover and Hill 2012) . By the time, the focus of investigation was mostly on sex specific differences in placental function (Cuffe et al., 2011; O'Connell et al., 2011) Unexpectedly, it was found that administration of high dose of DEX showed less angle change than the low dose of DEX did, as shown in Table 2 and Fig. 3 . In a similar way, embryonic weight and size were less affected by prenatal administration of DEX10 than DEX1 (Yun et al., 2014) . Although it is not clear how embryos strive for survival, there should be some complementary mechanisms to overcome unfavorable intrauterine conditions, which could be one reason for less effect with high dose of DEX. We have already demonstrated that a subgroup of placentas from DEX10-injected mother was enlarged with structural abnormalities (Lee et al., 2012) . Placentomegaly has been also observed in maternally stressed animal models and human, and therefore, it was regarded as a complementary survival strategy to adapt to an adverse condition (Faichney and White 1987; Lumey 1998; McCrabb et al., 1992; Tegethoff et al., 2010) .
In summary, our results demonstrate that prenatal exposure to DEX in mice induces fetal skeletal malformations.
Although all of the observable skeletal phenotypes in prenatal stress models of previously published studies are not identical, it should be determined by the timing and the amount of fetal exposure to stress, and by the genetic susceptibility. Therefore, all outcomes from individual studies might provide valuable information and understanding how prenatal maternal stress can affect a developing fetus. Further investigations on the molecular basis behind the phenotypes would be helpful to evaluate the effects on fetal skeletal system.
